Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non ‐small cell lung cancer patients

ConclusionOur results indicate that PSPH may act as a putative oncogene in NSCLC, and may be a vital molecular marker for the metastasis and proliferation of NSCLC cells by regulating the AKT/AMPK signaling pathway.

Source: Thoracic Cancer - April 10, 2019 Category: Cancer & Oncology Authors: Li Liao, Huajian Yu, Mengxi Ge, Qiong Zhan, Ruofan Huang, Xiaoyu Ji, Xiaohua Liang, Xinli Zhou Tags: ORIGINAL ARTICLE Source Type: research